CGON vs WYNN · rev $4.0M vs P/E 29, rev $3.71B
CG Oncology, Inc. Common stock (CGON) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
CGON currently screens at market cap $4.74B. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the CGON and WYNN stock pages for the full models.
Not investment advice.